Acquired Company
Virios Therapeutics was acquired by Wex Pharmaceuticals (an indirect CK Life Sciences subsidiary) in an all-stock transaction to form Dogwood Therapeutics, Inc.; Virios’ stock will cease trading under VIRI and begin trading under DWTX on October 9, 2024.
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$2.36
Open
$2.37
Volume
70,171
Day Range
$2.25 - $2.38
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|